Aplastic Anemia Patient & Family Handbook

n BIBLIOGRAFÍA

Bacigalupo, A. (2017). How I treat acquired aplastic anemia. Blood, 129 (11), 1428–1436. Marsh, J. C., & Kulasekararaj, A. G. (2013). Management of the refractory aplastic anemia patient: what are the options?. ASH Education Program Book, 2013 (1), 87–94. Scheinberg, P. (2018). Activity of eltrombopag in severe aplastic anemia. Blood advances, 2 (21), 3054–3062. Scheinberg, P., & Young, N. S. (2012). How I treat acquired aplastic anemia. Blood, 120 (6), 1185–1196. Townsley, D. M., et al. (2017). Eltrombopag added to standard immunosuppression for aplastic anemia. New England Journal of Medicine, 376 (16), 1540–1550. Williams, D. A., et al. (2014). Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): An initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC). Pediatric Blood & Cancer, 61 (5), 869–874.

n NÚMEROS TELEFÓNICOS IMPORTANTES

n NOTAS